Zhejiang Guobang Pharmaceutical Co., Ltd FDA Record
- Latest inspection VAI · Mar 3, 2025
- No warning letters matched by name
Zhejiang Guobang Pharmaceutical Co., Ltd has 0 FDA recalls, 3 inspections, 0 510(k) clearances and 0 compliance actions on record. No FDA warning letter addressed to "Zhejiang Guobang Pharmaceutical Co., Ltd" is on file.
- Latest inspection
- Mar 3, 2025 · VAI
Summary
| Records | Count | Last refreshed | Source as of | Status |
|---|---|---|---|---|
| Recalls | 0 | Nov 11, 2026 (checked Nov 15, 2026, unchanged) | File dated Nov 10, 2026 | Current |
| 510(k) clearances | 0 | Nov 15, 2026 | File dated Nov 9, 2026 | Current |
| Inspections | 3 | Nov 15, 2026 | Newest record Nov 5, 2026 | Current |
| Compliance actions | 0 | Nov 2, 2026 | Newest record Oct 29, 2026 | Current |
FDA record by year
Zhejiang Guobang Pharmaceutical Co., Ltd: FDA inspections per year
| Year | Inspections | OAI | Warning letters | Recall records | Class I |
|---|---|---|---|---|---|
| 2026 | 0 | 0 | 0 | 0 | 0 |
| 2025 | 1 | 0 | 0 | 0 | 0 |
| 2024 | 0 | 0 | 0 | 0 | 0 |
| 2023 | 0 | 0 | 0 | 0 | 0 |
| 2022 | 0 | 0 | 0 | 0 | 0 |
| 2021 | 0 | 0 | 0 | 0 | 0 |
| 2020 | 1 | 0 | 0 | 0 | 0 |
| 2019 | 0 | 0 | 0 | 0 | 0 |
| 2018 | 0 | 0 | 0 | 0 | 0 |
| 2017 | 0 | 0 | 0 | 0 | 0 |
Reviewing Zhejiang Guobang Pharmaceutical Co., Ltd as a supplier? Request a free FDA snapshot: name up to five suppliers and get a PDF of their public FDA record, with sources and dates. You do not need an API connection. Each snapshot is prepared by hand.
Or check Zhejiang Guobang Pharmaceutical Co., Ltd yourself in Claude, Cursor or ChatGPT: get the full FDA risk summary, with inspections, warning letters, Form 483s and import alerts by site.
Recent FDA inspections
| Date | Site | Product | Classification | FEI |
|---|---|---|---|---|
| Mar 3, 2025 | Shaoxing, China | Drugs | Voluntary Action Indicated (VAI) | 3008617115 |
| Jan 10, 2020 | Shaoxing, China | Drugs | Voluntary Action Indicated (VAI) | 3008617115 |
| Sep 24, 2015 | Shaoxing, China | Drugs | No Action Indicated (NAI) | 3008617115 |
- NAI
- No objectionable conditions or practices were found during the inspection.
- VAI
- Objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action.
- OAI
- Regulatory and/or administrative actions are recommended.
FDA-inspected facilities
| Facility | Location | Inspections | Latest |
|---|---|---|---|
| FEI 3008617115 | Shaoxing, China | 3 | Mar 3, 2025 |
Zhejiang Guobang Pharmaceutical Co., Ltd and the FDA: common questions
Has Zhejiang Guobang Pharmaceutical Co., Ltd received an FDA warning letter?
No FDA warning letter addressed to the name "Zhejiang Guobang Pharmaceutical Co., Ltd" is on file. This answer covers that name only: letters addressed to a related company name or to one of its sites are listed on that name's or site's own page.
Has Zhejiang Guobang Pharmaceutical Co., Ltd received an FDA Form 483?
FDA has not published a Form 483 for "Zhejiang Guobang Pharmaceutical Co., Ltd" in its reading room. FDA publishes some Form 483s, not all of them.
When did the FDA last inspect Zhejiang Guobang Pharmaceutical Co., Ltd?
The most recent FDA inspection on file ended Mar 3, 2025 at Shaoxing, China and was classified VAI. FDA has 3 inspections of Zhejiang Guobang Pharmaceutical Co., Ltd on file.
Need more than this page shows? Ask about Zhejiang Guobang Pharmaceutical Co., Ltd in Claude or ChatGPT and get every site's inspections, Form 483s, warning letters and import alerts, with a link to the FDA source for each record. The API key is free: no card.